Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Infections of the Upper Respiratory Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00967759
What this trial is testing

Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years Old

Who this might be right for
Common Cold
Ache Laboratorios Farmaceuticos S.A.
Early research (Phase 1)UnknownNCT04982068
What this trial is testing

Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Who this might be right for
COVID-19
Shanghai Zerun Biotechnology Co.,Ltd 72
Testing effectiveness (Phase 2)Study completedNCT03338556
What this trial is testing

Examine the Duration of Effect of PrEP-001 in Healthy Subjects Challenged With HRV-16

Who this might be right for
Viral Upper Respiratory Tract Infection
Prep Biopharm Limited 102
Post-approval studies (Phase 4)Study completedNCT05471531
What this trial is testing

Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

Who this might be right for
Influenza and Pneumonia
Sinovac Biotech Co., Ltd 3,000
Testing effectiveness (Phase 2)UnknownNCT04813562
What this trial is testing

Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 480
Testing effectiveness (Phase 2)Active Not RecruitingNCT07092865
What this trial is testing

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 168
Not applicableUnknownNCT01985620
What this trial is testing

The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.

Who this might be right for
PrematurityRSVInfluenza+2 more
Tel-Aviv Sourasky Medical Center 200
Not applicableStudy completedNCT02957136
What this trial is testing

Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department

Who this might be right for
Respiratory Tract InfectionsInfluenza, HumanCommon Cold
University of California, Davis 194
Large-scale testing (Phase 3)Active Not RecruitingNCT04732871
What this trial is testing

Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,720
Testing effectiveness (Phase 2)UnknownNCT04756323
What this trial is testing

Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

Who this might be right for
COVID-19
Beijing Minhai Biotechnology Co., Ltd 1,000
Testing effectiveness (Phase 2)Study completedNCT06361875
What this trial is testing

Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 908
Large-scale testing (Phase 3)Study completedNCT06389487
What this trial is testing

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,459
Large-scale testing (Phase 3)Study completedNCT00231218
What this trial is testing

Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers

Who this might be right for
Common ColdGastroenteritis
The Cleveland Clinic 104
Not applicableEnrolling By InvitationNCT07168759
What this trial is testing

Educational VR Game Intervention to Enhance Hygiene Practices in Primary School Children

Who this might be right for
Healthy Participants
The Hong Kong Polytechnic University 2,160
Post-approval studies (Phase 4)Study completedNCT01968434
What this trial is testing

Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children.

Who this might be right for
CoughUpper Respiratory Tract Infection
Clalit Health Services 150
Not applicableLooking for participantsNCT06998251
What this trial is testing

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn)

Who this might be right for
Pneumococcal InfectionsRespiratory Syncytial Virus (RSV) InfectionInfluenza Infection
University Hospital, Geneva 280
Testing effectiveness (Phase 2)UnknownNCT05313022
What this trial is testing

Safety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Who this might be right for
COVID-19
Shanghai Zerun Biotechnology Co.,Ltd 84
Post-approval studies (Phase 4)Study completedNCT05398926
What this trial is testing

Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 400
Large-scale testing (Phase 3)WithdrawnNCT04838847
What this trial is testing

Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19

Who this might be right for
CoronavirusCovid19SARS-CoV-2+1 more
CureVac
Not applicableActive Not RecruitingNCT06271655
What this trial is testing

Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)

Who this might be right for
Acute Respiratory InfectionViral InfectionUpper Respiratory Tract Infections
Christopher Payette 200
Next Page